Company profile

RNhale company profile

RNhale GmbH is a spin-off originating from the Ludwig-Maximilians-University Munich, aiming to revolutionize the pharmaceutical landscape by developing a unique platform technology for formulating RNA-loaded lipid nanoparticles (LNPs) as an inhalable dry powder. This disruptive approach synergizes technological and pharmaceutical strategies to create a novel therapeutic formulation with significant advantages over common LNP-RNA delivery methods. The target is pulmonary diseases with vast addressable markets and undeniable medical needs.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Founded
2023-01-01

Headquarters

Headquarters
Bayern, Germany, Planegg
Postal code
82152
Country code
DE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$2.6M
Last funding
Seed / $2.6M / 2025-01-01
Last equity funding
Seed / $2.6M
Investors
1
Founders
3
Articles
2

Founders and investors

Founders

Benjamin WinkeljannDavid JürgensLeonie Deßloch

Investors

European Innovation Council

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.